Ustekinumab reduces serum protein levels associated with cardiovascular risk in psoriasis vulgaris.
Saved in:
| Title: | Ustekinumab reduces serum protein levels associated with cardiovascular risk in psoriasis vulgaris. |
|---|---|
| Authors: | Koschitzky, Merav1,2 (AUTHOR) merav.koschitzky@icahn.mssm.edu, Navrazhina, Kristina1,3 (AUTHOR) knavrazhin@mail.rockefeller.edu, Garshick, Michael S.4 (AUTHOR), Gonzalez, Juana1 (AUTHOR) jgonzalez@mail.rockefeller.edu, Han, Joseph2 (AUTHOR) joseph.han@icahn.mssm.edu, Garcet, Sandra1 (AUTHOR) sgarcet@rockefeller.edu, Krueger, James G.1 (AUTHOR) kruegej@rockefeller.edu |
| Source: | Experimental Dermatology. Sep2022, Vol. 31 Issue 9, p1341-1351. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
